Determination of cidofovir in human plasma after low dose drug administration using high-performance liquid chromatography-tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 4, 2010, Pages 1015-1021

  Momper, Jeremiah D ^a   Zhang, Shimin ^a   Randhawa, Parmjeet S ^b   Shapiro, Ron ^b   Schonder, Kristine S ^a   Venkataramanan, Raman ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

BK virus; Cidofovir; Liquid chromatography mass spectrometry

Indexed keywords

AMMONIUM ACETATE; CIDOFOVIR; METHANOL;

ACCURACY; ARTICLE; BK VIRUS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY INFECTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; POLYOMA VIRUS; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

ANTIVIRAL AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOSINE; DRUG STABILITY; HUMANS; LIMIT OF DETECTION; PHOSPHONIC ACIDS; TANDEM MASS SPECTROMETRY;

EID: 77955581348     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.06.034     Document Type: Article

References (17)

1. Bronson J.J., Ferrara L.M., Hitchcock M.J., Ho H.T., Woods K.L., Ghazzouli I., Kern E.R., Soike K.F., Martin J.C. (S)-1-(3-hydroxy-2-(phosphonylmethoxy)propyl)cytosine (HPMPC): a potent antiherpesvirus agent. Adv. Exp. Med. Biol. 1990, 278:277-283.
2. de Oliveira C.B., Stevenson D., LaBree L., McDonnell P.J., Trousdale M.D. Evaluation of cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antiviral Res. 1996, 31:165-172.
3. Farasati N.A., Shapiro R., Vats A., Randhawa P. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 2005, 79:116-118.
4. Bernhoff E., Gutteberg T.J., Sandvik K., Hirsch H.H., Rinaldo C.H. Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression. Am. J. Transplant. 2008, 8:1413-1422.
5. Kuypers D.R., Vandooren A.K., Lerut E., Evenepoel P., Claes K., Snoeck R., Naesens L., Vanrenterghem Y. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am. J. Transplant. 2005, 5:1997-2004.
6. Vats A., Randhawa P.S., Shapiro R. Diagnosis and treatment of BK virus-associated transplant nephropathy. Adv. Exp. Med. Biol. 2006, 577:213-227.
7. Cabello V., Margarit N., Diaz Pedrero M., Bernal G., Pereira P., Gentil M.A. Treatment of BK virus-associated nephropathy with cidofovir in renal transplantation. Transplant. Proc. 2008, 40:2930-2932.
8. Lamoth F., Pascual M., Erard V., Venetz J.P., Nseir G., Meylan P. Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature. Antiviral Ther. 2008, 13:1001-1009.
9. Cundy K.C. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin. Pharmacokinet. 1999, 36:127-143.
10. Brody S.R., Humphreys M.H., Gambertoglio J.G., Schoenfeld P., Cundy K.C., Aweeka F.T. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis. Clin. Pharmacol. Ther. 1999, 65:21-28.
11. Eisenberg E.J., Cundy K.C. High-performance liquid chromatographic determination of cytosine-containing compounds by precolumn fluorescence derivatization with phenacyl bromide: application to antiviral nucleosides and nucleotides. J. Chromatogr. B 1996, 679:119-127.
12. Yuan L.C., Samuels G.J., Visor G.C. Stability of cidofovir in 0.9% sodium chloride injection and in 5% dextrose injection. Am. J. Health Syst. Pharm. 1996, 53:1939-1943.
13. Ba B.B., Saux M.C. Separation methods for antiviral phosphorus-containing drugs. J. Chromatogr. B: Biomed. Sci. Appl. 2001, 764:349-362.
14. Naiman A.N., Roger G., Gagnieu M.C., Bordenave J., Mathaut S., Ayari S., Nicollas R., Bour J.B., Garabedian N., Froehlich P. Cidofovir plasma assays after local injection in respiratory papillomatosis. The Laryngoscope 2004, 114:1151-1156.
15. Breddemann A., Hsien L., Tot E., Laer S. Quantification of cidofovir in human serum by LC-MS/MS for children. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2008, 861:1-9.
16. U.S.Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), and Center for Veterinary Medicine (CVM) Guidance for Industry-Bioanalytical Method Validation 2001, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf.
17. Rosing H., Man W.Y., Doyle E., Bult A., Beijnen J.H. Bioanalytical liquid chromatographic method validation. A review of current practices and procedures. J. Liq. Chromatogr. Relat. Technol. 2000, 23:329-354.